Avidity Partners Management LP lessened its stake in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Free Report) by 96.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 64,501 shares of the company’s stock after selling 1,692,439 shares during the quarter. Avidity Partners Management […]
Primecap Management Co. CA purchased a new stake in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 304,900 shares of the company’s stock, valued at approximately $5,583,000. Primecap Management Co. CA owned […]
Sphera Funds Management LTD. bought a new position in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 100,000 shares of the company’s stock, valued at approximately $2,157,000. Several other large investors have also bought and sold shares […]
Emerald Mutual Fund Advisers Trust increased its stake in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Free Report) by 20.5% in the first quarter, HoldingsChannel.com reports. The firm owned 789,591 shares of the company’s stock after buying an additional 134,576 shares during the period. Amylyx Pharmaceuticals accounts for approximately 1.4% of Emerald Mutual Fund Advisers […]